<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="cfr.xsl"?>
<CFRGRANULE xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="CFRMergedXML.xsd">
  <FDSYS>
    <CFRTITLE>21</CFRTITLE>
    <CFRTITLETEXT>Food and Drugs</CFRTITLETEXT>
    <VOL>4</VOL>
    <DATE>2000-04-01</DATE>
    <ORIGINALDATE>2000-04-01</ORIGINALDATE>
    <COVERONLY>false</COVERONLY>
    <TITLE>Filters.</TITLE>
    <GRANULENUM>211.72</GRANULENUM>
    <HEADING>Section 211.72</HEADING>
    <ANCESTORS>
      <PARENT HEADING="Title 21" SEQ="4">Food and Drugs</PARENT>
      <PARENT HEADING="" SEQ="3"/>
      <PARENT HEADING="SUBCHAPTER C" SEQ="2">DRUGS: GENERAL</PARENT>
      <PARENT HEADING="PART 211" SEQ="1">CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS</PARENT>
      <PARENT HEADING="Subpart D" SEQ="0">Equipment</PARENT>
    </ANCESTORS>
  </FDSYS>
  <SECTION>
    <SECTNO>§ 211.72</SECTNO>
    <SUBJECT>Filters.</SUBJECT>
    <P>Filters for liquid filtration used in the manufacture, processing, or packing of injectable drug products intended for human use shall not release fibers into such products. Fiber-releasing filters may not be used in the manufacture, processing, or packing of these injectable drug products unless it is not possible to manufacture such drug products without the use of such filters. If use of a fiber-releasing filter is necessary, an additional non-fiber-releasing filter of 0.22 micron maximum mean porosity (0.45 micron if the manufacturing conditions so dictate) shall subsequently be used to reduce the content of particles in the injectable drug product. Use of an asbestos-containing filter, with or without subsequent use of a specific non-fiber-releasing filter, is permissible only upon submission of proof to the appropriate bureau of the Food and Drug Administration that use of a non-fiber-releasing filter will, or is likely to, compromise the safety or effectiveness of the injectable drug product.</P>
  </SECTION>
</CFRGRANULE>
